금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Nasdaq Futures Slide Premarket As AI Spending Worries Resurface — Oil Tops $112 On Iran Tensions, Supply Concerns
Lam Research and Tesla led losses as investors reassessed AI spending, while fears of renewed milita...
Tech, Oil Worries Undercut Wall Street Pre-Bell; Asia, Europe Down
Wall Street futures pointed lower pre-bell Thursday on mounting Persian Gulf hostilities and crude p...
Fed preview: On hold in October, hiking resumes later
The Fed began its hiking cycle with a 25bp hike at the September meeting, but we expect rates to sta...
Why Is Grocery Outlet (GO) Up 22.8% Since Last Earnings Report?
Grocery Outlet (GO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Europe Wary Of Too Much Dependence on U.S. LNG
European buyers aren’t committing to long-term LNG supply agreements with U.S. exporters despite the ongoing EU phase-out of Russian gas imports and the supply crisis in the Middle East. U.S. develope ...
CarMax, In Turnaround Mode, Scores Breakout Before Earnings; AI Investors Eye Jabil Results
CarMax stock is in turnaround mode with a new CEO ahead of its upcoming earnings report, while AI investors await earnings from Jabil.
GraniteShares YieldBOOST Single Stock Universe ETF declares $0.1366 dividend
GraniteShares YieldBOOST TopYielders ETF declares $0.1352 dividend
My company fired one manager and is doing an ‘organizational reshuffling.’ Am I in trouble?
“They let go of a pretty high-up manager who they only hired a month ago.”
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its so ...
Guardant rated new Outperform at RBC on catalysts, growth prospects
3 Reasons to Sell BALL and 1 Stock to Buy Instead
Ball trades at $56.29 per share and has stayed right on track with the overall market, gaining 10.6% over the last six months. At the same time, the S&P 500 has returned 6.4%.
Veeva Expands Safety Suite Footprint With UCB Pharmacovigilance Deal
VEEV's UCB pharmacovigilance deal expands Safety Suite adoption, supporting automation, compliance and long-term growth opportunities.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
3 Reasons to Sell FFBC and 1 Stock to Buy Instead
Over the past six months, First Financial Bancorp has been a great trade, beating the S&P 500 by 12%. Its stock price has climbed to $31.78, representing a healthy 18.4% increase. This was partly than ...